PubMed Health⌕ Search

Biomedical subjects

Noëlle Lenoir

Publications and source records attributed to Noëlle Lenoir.

4 recordsLinked to original sources
PubMed2002

[Bioethics and the 21st century, viewpoint of the jurist].

It is essential to approach the question of protection of human life from a legal point of view, because the developments in reproductive biology and the new research fields on the embryo and the so called 'stem' cells, imply the establishment of new laws. This is a real challenge, since to infer rights to the onset of life means that the embryo or the foetus has to have a status. The European Ethics Group has to provide propositions concerning the ethical aspects of embryo research, related to research on the 'stem' cells. In fact, Europe is confronted with several problems related to the cultural, legal and religious pluralism and the market regulations. Reflections on embryos must no longer be based on the search of means to improve reproduction techniques, but on their use as simple cell producers. Some suggestions can be made in favour of a mutual European approach to bioethics: research and medicine devoted to the onset of life must be submitted to strict public control; the status of the embryo must be clarified; recommendations have to be drawn-up regarding so-called 'therapeutic' cloning; and International laws concerning bioethics must be established.

Cloning, Organism↗
PubMed1997

UNESCO, genetics, and human rights.

In response to a mandate conferred on the International Bioethics Committee (IBC) of UNESCO in November 1993, the IBC has drafted a "universal declaration on the human genome and human rights," which will be considered by the General Conference of UNESCO in November 1997. This article discusses the development of the document and provides the text of the "revised preliminary draft" of the declaration.

Advisory Committees↗
PubMedDate not supplied

Patentability of life and ethics.

Patent law has relied in part on ethical considerations since its inception in Europe. Such considerations have been introduced more recently in the United States. Whereas the EU Directive on the protection on the occasion of the Human Genome Project of biotechnological inventions was intended to foster economic development in Europe, its implementation is outweighted by controversy about patenting life and commercialization of science. The confusion created must be cleared at the international level through harmonization of patent office policies preventing abusive commercial practices in the absence of inventiveness.

Biotechnology↗